Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
Keywords: ACS; acute coronary syndrome; CURE; Clopidogrel in Unstable angina to prevent Recurrent Events trial; DRG; diagnosis-related group; ICER; incremental cost-effectiveness ratio; MI; myocardial infarction; LOS; length of stay; LYG; life-year gained; PCI; per